“Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022056. doi:10.4084/MJHID.2022.056.